Enhanced therapeutic efficacy of silibinin loaded silica coated magnetic nanocomposites against Pseudomonas aeruginosa in Combination with Ciprofloxacin and HepG2 cancer cells Article Swipe
Sanaz Borji
,
Mahdi Shahriarinour
,
Shahab Shariati
,
Najmeh Ranji
,
Mohammad Nikpassand
·
YOU?
·
· 2025
· Open Access
·
· DOI: https://doi.org/10.1038/s41598-025-07529-x
YOU?
·
· 2025
· Open Access
·
· DOI: https://doi.org/10.1038/s41598-025-07529-x
Silibinin, a major bioactive compound extracted from Silybum marianum, possesses notable antioxidant, antitumor, hepatoprotective, and antibacterial activities. However, its poor solubility limits its clinical applications. This study aimed to enhance the delivery of silibinin by synthesizing magnetic nanocomposites (MNCs) and evaluating their efficacy against clinical isolates of Pseudomonas aeruginosa and HepG2 cancer cells. The physicochemical properties of the Fe3O4@SiPr@Silibinin nanocomposites were characterized by FT-IR, TGA-DTG, TEM, FE-SEM, XRD, and VSM analysis. Clinical isolates and a standard strain of P. aeruginosa were treated with Fe3O4@SiPr@Silibinin (at sub-MIC level) in combination with ciprofloxacin (sub-MIC), and the results were compared to treatment with ciprofloxacin alone. Additionally, the anticancer effects of Fe3O4@SiPr@Silibinin were evaluated in HepG2 cells. The nanocomposites, with particle sizes ranging from 40 to 80 nm, significantly enhanced the antimicrobial activity of ciprofloxacin when used in combination. Treatment with Fe3O4@SiPr@Silibinin plus ciprofloxacin led to a downregulation of biofilm and efflux pump-related gene expression compared to ciprofloxacin treatment alone. Furthermore, Fe3O4@SiPr@Silibinin exhibited anti-cancer activity against HepG2 cells, with an IC₅₀ value of 35.79 µg/mL In Silibinin-treated HepG2 cells, upregulation of the P53 gene and downregulation of the Bcl2 gene were observed. Our findingssuggest that Fe3O4@SiPr@Silibinin MNCs, with high stability and water solublity, can efficiently deliver silibinin into pathogenic and tumorigenic cells, thereby enhancing its therapeutic effects against P. aeruginosa and HepG2 cells. Given the antimicrobial and antitumor properties of silibinin, these magnetic nanocarriers represent a promising strategy for its targeted delivery.
Related Topics
Concepts
Metadata
- Type
- article
- Language
- en
- Landing Page
- https://doi.org/10.1038/s41598-025-07529-x
- OA Status
- gold
- Cited By
- 1
- References
- 86
- Related Works
- 10
- OpenAlex ID
- https://openalex.org/W4411865391
All OpenAlex metadata
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W4411865391Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.1038/s41598-025-07529-xDigital Object Identifier
- Title
-
Enhanced therapeutic efficacy of silibinin loaded silica coated magnetic nanocomposites against Pseudomonas aeruginosa in Combination with Ciprofloxacin and HepG2 cancer cellsWork title
- Type
-
articleOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2025Year of publication
- Publication date
-
2025-07-01Full publication date if available
- Authors
-
Sanaz Borji, Mahdi Shahriarinour, Shahab Shariati, Najmeh Ranji, Mohammad NikpassandList of authors in order
- Landing page
-
https://doi.org/10.1038/s41598-025-07529-xPublisher landing page
- Open access
-
YesWhether a free full text is available
- OA status
-
goldOpen access status per OpenAlex
- OA URL
-
https://doi.org/10.1038/s41598-025-07529-xDirect OA link when available
- Concepts
-
Pseudomonas aeruginosa, Silibinin, Ciprofloxacin, Nanocomposite, Cancer research, Microbiology, Chemistry, Medicine, Pharmacology, Materials science, Nanotechnology, Biology, Bacteria, Antibiotics, GeneticsTop concepts (fields/topics) attached by OpenAlex
- Cited by
-
1Total citation count in OpenAlex
- Citations by year (recent)
-
2025: 1Per-year citation counts (last 5 years)
- References (count)
-
86Number of works referenced by this work
- Related works (count)
-
10Other works algorithmically related by OpenAlex
Full payload
| id | https://openalex.org/W4411865391 |
|---|---|
| doi | https://doi.org/10.1038/s41598-025-07529-x |
| ids.doi | https://doi.org/10.1038/s41598-025-07529-x |
| ids.pmid | https://pubmed.ncbi.nlm.nih.gov/40596538 |
| ids.openalex | https://openalex.org/W4411865391 |
| fwci | 2.08063354 |
| mesh[0].qualifier_ui | |
| mesh[0].descriptor_ui | D006801 |
| mesh[0].is_major_topic | False |
| mesh[0].qualifier_name | |
| mesh[0].descriptor_name | Humans |
| mesh[1].qualifier_ui | Q000494 |
| mesh[1].descriptor_ui | D002939 |
| mesh[1].is_major_topic | True |
| mesh[1].qualifier_name | pharmacology |
| mesh[1].descriptor_name | Ciprofloxacin |
| mesh[2].qualifier_ui | Q000187 |
| mesh[2].descriptor_ui | D011550 |
| mesh[2].is_major_topic | True |
| mesh[2].qualifier_name | drug effects |
| mesh[2].descriptor_name | Pseudomonas aeruginosa |
| mesh[3].qualifier_ui | |
| mesh[3].descriptor_ui | D056945 |
| mesh[3].is_major_topic | False |
| mesh[3].qualifier_name | |
| mesh[3].descriptor_name | Hep G2 Cells |
| mesh[4].qualifier_ui | Q000494 |
| mesh[4].descriptor_ui | D000077385 |
| mesh[4].is_major_topic | True |
| mesh[4].qualifier_name | pharmacology |
| mesh[4].descriptor_name | Silybin |
| mesh[5].qualifier_ui | Q000737 |
| mesh[5].descriptor_ui | D053761 |
| mesh[5].is_major_topic | True |
| mesh[5].qualifier_name | chemistry |
| mesh[5].descriptor_name | Nanocomposites |
| mesh[6].qualifier_ui | Q000494 |
| mesh[6].descriptor_ui | D000900 |
| mesh[6].is_major_topic | True |
| mesh[6].qualifier_name | pharmacology |
| mesh[6].descriptor_name | Anti-Bacterial Agents |
| mesh[7].qualifier_ui | Q000737 |
| mesh[7].descriptor_ui | D000900 |
| mesh[7].is_major_topic | True |
| mesh[7].qualifier_name | chemistry |
| mesh[7].descriptor_name | Anti-Bacterial Agents |
| mesh[8].qualifier_ui | Q000737 |
| mesh[8].descriptor_ui | D012822 |
| mesh[8].is_major_topic | False |
| mesh[8].qualifier_name | chemistry |
| mesh[8].descriptor_name | Silicon Dioxide |
| mesh[9].qualifier_ui | |
| mesh[9].descriptor_ui | D008826 |
| mesh[9].is_major_topic | False |
| mesh[9].qualifier_name | |
| mesh[9].descriptor_name | Microbial Sensitivity Tests |
| mesh[10].qualifier_ui | Q000187 |
| mesh[10].descriptor_ui | D018441 |
| mesh[10].is_major_topic | False |
| mesh[10].qualifier_name | drug effects |
| mesh[10].descriptor_name | Biofilms |
| mesh[11].qualifier_ui | Q000494 |
| mesh[11].descriptor_ui | D000970 |
| mesh[11].is_major_topic | False |
| mesh[11].qualifier_name | pharmacology |
| mesh[11].descriptor_name | Antineoplastic Agents |
| mesh[12].qualifier_ui | |
| mesh[12].descriptor_ui | D006801 |
| mesh[12].is_major_topic | False |
| mesh[12].qualifier_name | |
| mesh[12].descriptor_name | Humans |
| mesh[13].qualifier_ui | Q000494 |
| mesh[13].descriptor_ui | D002939 |
| mesh[13].is_major_topic | True |
| mesh[13].qualifier_name | pharmacology |
| mesh[13].descriptor_name | Ciprofloxacin |
| mesh[14].qualifier_ui | Q000187 |
| mesh[14].descriptor_ui | D011550 |
| mesh[14].is_major_topic | True |
| mesh[14].qualifier_name | drug effects |
| mesh[14].descriptor_name | Pseudomonas aeruginosa |
| mesh[15].qualifier_ui | |
| mesh[15].descriptor_ui | D056945 |
| mesh[15].is_major_topic | False |
| mesh[15].qualifier_name | |
| mesh[15].descriptor_name | Hep G2 Cells |
| mesh[16].qualifier_ui | Q000494 |
| mesh[16].descriptor_ui | D000077385 |
| mesh[16].is_major_topic | True |
| mesh[16].qualifier_name | pharmacology |
| mesh[16].descriptor_name | Silybin |
| mesh[17].qualifier_ui | Q000737 |
| mesh[17].descriptor_ui | D053761 |
| mesh[17].is_major_topic | True |
| mesh[17].qualifier_name | chemistry |
| mesh[17].descriptor_name | Nanocomposites |
| mesh[18].qualifier_ui | Q000494 |
| mesh[18].descriptor_ui | D000900 |
| mesh[18].is_major_topic | True |
| mesh[18].qualifier_name | pharmacology |
| mesh[18].descriptor_name | Anti-Bacterial Agents |
| mesh[19].qualifier_ui | Q000737 |
| mesh[19].descriptor_ui | D000900 |
| mesh[19].is_major_topic | True |
| mesh[19].qualifier_name | chemistry |
| mesh[19].descriptor_name | Anti-Bacterial Agents |
| mesh[20].qualifier_ui | Q000737 |
| mesh[20].descriptor_ui | D012822 |
| mesh[20].is_major_topic | False |
| mesh[20].qualifier_name | chemistry |
| mesh[20].descriptor_name | Silicon Dioxide |
| mesh[21].qualifier_ui | |
| mesh[21].descriptor_ui | D008826 |
| mesh[21].is_major_topic | False |
| mesh[21].qualifier_name | |
| mesh[21].descriptor_name | Microbial Sensitivity Tests |
| mesh[22].qualifier_ui | Q000187 |
| mesh[22].descriptor_ui | D018441 |
| mesh[22].is_major_topic | False |
| mesh[22].qualifier_name | drug effects |
| mesh[22].descriptor_name | Biofilms |
| mesh[23].qualifier_ui | Q000494 |
| mesh[23].descriptor_ui | D000970 |
| mesh[23].is_major_topic | False |
| mesh[23].qualifier_name | pharmacology |
| mesh[23].descriptor_name | Antineoplastic Agents |
| mesh[24].qualifier_ui | |
| mesh[24].descriptor_ui | D006801 |
| mesh[24].is_major_topic | False |
| mesh[24].qualifier_name | |
| mesh[24].descriptor_name | Humans |
| mesh[25].qualifier_ui | Q000494 |
| mesh[25].descriptor_ui | D002939 |
| mesh[25].is_major_topic | True |
| mesh[25].qualifier_name | pharmacology |
| mesh[25].descriptor_name | Ciprofloxacin |
| mesh[26].qualifier_ui | Q000187 |
| mesh[26].descriptor_ui | D011550 |
| mesh[26].is_major_topic | True |
| mesh[26].qualifier_name | drug effects |
| mesh[26].descriptor_name | Pseudomonas aeruginosa |
| mesh[27].qualifier_ui | |
| mesh[27].descriptor_ui | D056945 |
| mesh[27].is_major_topic | False |
| mesh[27].qualifier_name | |
| mesh[27].descriptor_name | Hep G2 Cells |
| mesh[28].qualifier_ui | Q000494 |
| mesh[28].descriptor_ui | D000077385 |
| mesh[28].is_major_topic | True |
| mesh[28].qualifier_name | pharmacology |
| mesh[28].descriptor_name | Silybin |
| mesh[29].qualifier_ui | Q000737 |
| mesh[29].descriptor_ui | D053761 |
| mesh[29].is_major_topic | True |
| mesh[29].qualifier_name | chemistry |
| mesh[29].descriptor_name | Nanocomposites |
| mesh[30].qualifier_ui | Q000494 |
| mesh[30].descriptor_ui | D000900 |
| mesh[30].is_major_topic | True |
| mesh[30].qualifier_name | pharmacology |
| mesh[30].descriptor_name | Anti-Bacterial Agents |
| mesh[31].qualifier_ui | Q000737 |
| mesh[31].descriptor_ui | D000900 |
| mesh[31].is_major_topic | True |
| mesh[31].qualifier_name | chemistry |
| mesh[31].descriptor_name | Anti-Bacterial Agents |
| mesh[32].qualifier_ui | Q000737 |
| mesh[32].descriptor_ui | D012822 |
| mesh[32].is_major_topic | False |
| mesh[32].qualifier_name | chemistry |
| mesh[32].descriptor_name | Silicon Dioxide |
| mesh[33].qualifier_ui | |
| mesh[33].descriptor_ui | D008826 |
| mesh[33].is_major_topic | False |
| mesh[33].qualifier_name | |
| mesh[33].descriptor_name | Microbial Sensitivity Tests |
| mesh[34].qualifier_ui | Q000187 |
| mesh[34].descriptor_ui | D018441 |
| mesh[34].is_major_topic | False |
| mesh[34].qualifier_name | drug effects |
| mesh[34].descriptor_name | Biofilms |
| mesh[35].qualifier_ui | Q000494 |
| mesh[35].descriptor_ui | D000970 |
| mesh[35].is_major_topic | False |
| mesh[35].qualifier_name | pharmacology |
| mesh[35].descriptor_name | Antineoplastic Agents |
| type | article |
| title | Enhanced therapeutic efficacy of silibinin loaded silica coated magnetic nanocomposites against Pseudomonas aeruginosa in Combination with Ciprofloxacin and HepG2 cancer cells |
| biblio.issue | 1 |
| biblio.volume | 15 |
| biblio.last_page | 21498 |
| biblio.first_page | 21498 |
| topics[0].id | https://openalex.org/T10063 |
| topics[0].field.id | https://openalex.org/fields/25 |
| topics[0].field.display_name | Materials Science |
| topics[0].score | 0.9979000091552734 |
| topics[0].domain.id | https://openalex.org/domains/3 |
| topics[0].domain.display_name | Physical Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/2502 |
| topics[0].subfield.display_name | Biomaterials |
| topics[0].display_name | Nanoparticle-Based Drug Delivery |
| topics[1].id | https://openalex.org/T12689 |
| topics[1].field.id | https://openalex.org/fields/27 |
| topics[1].field.display_name | Medicine |
| topics[1].score | 0.9950000047683716 |
| topics[1].domain.id | https://openalex.org/domains/4 |
| topics[1].domain.display_name | Health Sciences |
| topics[1].subfield.id | https://openalex.org/subfields/2740 |
| topics[1].subfield.display_name | Pulmonary and Respiratory Medicine |
| topics[1].display_name | Silymarin and Mushroom Poisoning |
| topics[2].id | https://openalex.org/T11319 |
| topics[2].field.id | https://openalex.org/fields/13 |
| topics[2].field.display_name | Biochemistry, Genetics and Molecular Biology |
| topics[2].score | 0.9944999814033508 |
| topics[2].domain.id | https://openalex.org/domains/1 |
| topics[2].domain.display_name | Life Sciences |
| topics[2].subfield.id | https://openalex.org/subfields/1313 |
| topics[2].subfield.display_name | Molecular Medicine |
| topics[2].display_name | Curcumin's Biomedical Applications |
| is_xpac | False |
| apc_list.value | 1890 |
| apc_list.currency | EUR |
| apc_list.value_usd | 2190 |
| apc_paid.value | 1890 |
| apc_paid.currency | EUR |
| apc_paid.value_usd | 2190 |
| concepts[0].id | https://openalex.org/C2777637488 |
| concepts[0].level | 3 |
| concepts[0].score | 0.7882604002952576 |
| concepts[0].wikidata | https://www.wikidata.org/wiki/Q31856 |
| concepts[0].display_name | Pseudomonas aeruginosa |
| concepts[1].id | https://openalex.org/C2777130413 |
| concepts[1].level | 2 |
| concepts[1].score | 0.7829107046127319 |
| concepts[1].wikidata | https://www.wikidata.org/wiki/Q425702 |
| concepts[1].display_name | Silibinin |
| concepts[2].id | https://openalex.org/C2778512257 |
| concepts[2].level | 3 |
| concepts[2].score | 0.6635371446609497 |
| concepts[2].wikidata | https://www.wikidata.org/wiki/Q256602 |
| concepts[2].display_name | Ciprofloxacin |
| concepts[3].id | https://openalex.org/C92880739 |
| concepts[3].level | 2 |
| concepts[3].score | 0.634337842464447 |
| concepts[3].wikidata | https://www.wikidata.org/wiki/Q2639556 |
| concepts[3].display_name | Nanocomposite |
| concepts[4].id | https://openalex.org/C502942594 |
| concepts[4].level | 1 |
| concepts[4].score | 0.4217606782913208 |
| concepts[4].wikidata | https://www.wikidata.org/wiki/Q3421914 |
| concepts[4].display_name | Cancer research |
| concepts[5].id | https://openalex.org/C89423630 |
| concepts[5].level | 1 |
| concepts[5].score | 0.42166462540626526 |
| concepts[5].wikidata | https://www.wikidata.org/wiki/Q7193 |
| concepts[5].display_name | Microbiology |
| concepts[6].id | https://openalex.org/C185592680 |
| concepts[6].level | 0 |
| concepts[6].score | 0.3917697072029114 |
| concepts[6].wikidata | https://www.wikidata.org/wiki/Q2329 |
| concepts[6].display_name | Chemistry |
| concepts[7].id | https://openalex.org/C71924100 |
| concepts[7].level | 0 |
| concepts[7].score | 0.34728479385375977 |
| concepts[7].wikidata | https://www.wikidata.org/wiki/Q11190 |
| concepts[7].display_name | Medicine |
| concepts[8].id | https://openalex.org/C98274493 |
| concepts[8].level | 1 |
| concepts[8].score | 0.3404006361961365 |
| concepts[8].wikidata | https://www.wikidata.org/wiki/Q128406 |
| concepts[8].display_name | Pharmacology |
| concepts[9].id | https://openalex.org/C192562407 |
| concepts[9].level | 0 |
| concepts[9].score | 0.31982842087745667 |
| concepts[9].wikidata | https://www.wikidata.org/wiki/Q228736 |
| concepts[9].display_name | Materials science |
| concepts[10].id | https://openalex.org/C171250308 |
| concepts[10].level | 1 |
| concepts[10].score | 0.23034897446632385 |
| concepts[10].wikidata | https://www.wikidata.org/wiki/Q11468 |
| concepts[10].display_name | Nanotechnology |
| concepts[11].id | https://openalex.org/C86803240 |
| concepts[11].level | 0 |
| concepts[11].score | 0.1466923952102661 |
| concepts[11].wikidata | https://www.wikidata.org/wiki/Q420 |
| concepts[11].display_name | Biology |
| concepts[12].id | https://openalex.org/C523546767 |
| concepts[12].level | 2 |
| concepts[12].score | 0.09694752097129822 |
| concepts[12].wikidata | https://www.wikidata.org/wiki/Q10876 |
| concepts[12].display_name | Bacteria |
| concepts[13].id | https://openalex.org/C501593827 |
| concepts[13].level | 2 |
| concepts[13].score | 0.057769715785980225 |
| concepts[13].wikidata | https://www.wikidata.org/wiki/Q12187 |
| concepts[13].display_name | Antibiotics |
| concepts[14].id | https://openalex.org/C54355233 |
| concepts[14].level | 1 |
| concepts[14].score | 0.0 |
| concepts[14].wikidata | https://www.wikidata.org/wiki/Q7162 |
| concepts[14].display_name | Genetics |
| keywords[0].id | https://openalex.org/keywords/pseudomonas-aeruginosa |
| keywords[0].score | 0.7882604002952576 |
| keywords[0].display_name | Pseudomonas aeruginosa |
| keywords[1].id | https://openalex.org/keywords/silibinin |
| keywords[1].score | 0.7829107046127319 |
| keywords[1].display_name | Silibinin |
| keywords[2].id | https://openalex.org/keywords/ciprofloxacin |
| keywords[2].score | 0.6635371446609497 |
| keywords[2].display_name | Ciprofloxacin |
| keywords[3].id | https://openalex.org/keywords/nanocomposite |
| keywords[3].score | 0.634337842464447 |
| keywords[3].display_name | Nanocomposite |
| keywords[4].id | https://openalex.org/keywords/cancer-research |
| keywords[4].score | 0.4217606782913208 |
| keywords[4].display_name | Cancer research |
| keywords[5].id | https://openalex.org/keywords/microbiology |
| keywords[5].score | 0.42166462540626526 |
| keywords[5].display_name | Microbiology |
| keywords[6].id | https://openalex.org/keywords/chemistry |
| keywords[6].score | 0.3917697072029114 |
| keywords[6].display_name | Chemistry |
| keywords[7].id | https://openalex.org/keywords/medicine |
| keywords[7].score | 0.34728479385375977 |
| keywords[7].display_name | Medicine |
| keywords[8].id | https://openalex.org/keywords/pharmacology |
| keywords[8].score | 0.3404006361961365 |
| keywords[8].display_name | Pharmacology |
| keywords[9].id | https://openalex.org/keywords/materials-science |
| keywords[9].score | 0.31982842087745667 |
| keywords[9].display_name | Materials science |
| keywords[10].id | https://openalex.org/keywords/nanotechnology |
| keywords[10].score | 0.23034897446632385 |
| keywords[10].display_name | Nanotechnology |
| keywords[11].id | https://openalex.org/keywords/biology |
| keywords[11].score | 0.1466923952102661 |
| keywords[11].display_name | Biology |
| keywords[12].id | https://openalex.org/keywords/bacteria |
| keywords[12].score | 0.09694752097129822 |
| keywords[12].display_name | Bacteria |
| keywords[13].id | https://openalex.org/keywords/antibiotics |
| keywords[13].score | 0.057769715785980225 |
| keywords[13].display_name | Antibiotics |
| language | en |
| locations[0].id | doi:10.1038/s41598-025-07529-x |
| locations[0].is_oa | True |
| locations[0].source.id | https://openalex.org/S196734849 |
| locations[0].source.issn | 2045-2322 |
| locations[0].source.type | journal |
| locations[0].source.is_oa | True |
| locations[0].source.issn_l | 2045-2322 |
| locations[0].source.is_core | True |
| locations[0].source.is_in_doaj | True |
| locations[0].source.display_name | Scientific Reports |
| locations[0].source.host_organization | https://openalex.org/P4310319908 |
| locations[0].source.host_organization_name | Nature Portfolio |
| locations[0].source.host_organization_lineage | https://openalex.org/P4310319908 |
| locations[0].license | |
| locations[0].pdf_url | |
| locations[0].version | publishedVersion |
| locations[0].raw_type | journal-article |
| locations[0].license_id | |
| locations[0].is_accepted | True |
| locations[0].is_published | True |
| locations[0].raw_source_name | Scientific Reports |
| locations[0].landing_page_url | https://doi.org/10.1038/s41598-025-07529-x |
| locations[1].id | pmid:40596538 |
| locations[1].is_oa | False |
| locations[1].source.id | https://openalex.org/S4306525036 |
| locations[1].source.issn | |
| locations[1].source.type | repository |
| locations[1].source.is_oa | False |
| locations[1].source.issn_l | |
| locations[1].source.is_core | False |
| locations[1].source.is_in_doaj | False |
| locations[1].source.display_name | PubMed |
| locations[1].source.host_organization | https://openalex.org/I1299303238 |
| locations[1].source.host_organization_name | National Institutes of Health |
| locations[1].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[1].license | |
| locations[1].pdf_url | |
| locations[1].version | publishedVersion |
| locations[1].raw_type | |
| locations[1].license_id | |
| locations[1].is_accepted | True |
| locations[1].is_published | True |
| locations[1].raw_source_name | Scientific reports |
| locations[1].landing_page_url | https://pubmed.ncbi.nlm.nih.gov/40596538 |
| locations[2].id | pmh:oai:doaj.org/article:306a59ad41ad4def9ec6d01a672224c3 |
| locations[2].is_oa | False |
| locations[2].source.id | https://openalex.org/S4306401280 |
| locations[2].source.issn | |
| locations[2].source.type | repository |
| locations[2].source.is_oa | False |
| locations[2].source.issn_l | |
| locations[2].source.is_core | False |
| locations[2].source.is_in_doaj | False |
| locations[2].source.display_name | DOAJ (DOAJ: Directory of Open Access Journals) |
| locations[2].source.host_organization | |
| locations[2].source.host_organization_name | |
| locations[2].source.host_organization_lineage | |
| locations[2].license | |
| locations[2].pdf_url | |
| locations[2].version | submittedVersion |
| locations[2].raw_type | article |
| locations[2].license_id | |
| locations[2].is_accepted | False |
| locations[2].is_published | False |
| locations[2].raw_source_name | Scientific Reports, Vol 15, Iss 1, Pp 1-17 (2025) |
| locations[2].landing_page_url | https://doaj.org/article/306a59ad41ad4def9ec6d01a672224c3 |
| locations[3].id | pmh:oai:pubmedcentral.nih.gov:12217157 |
| locations[3].is_oa | True |
| locations[3].source.id | https://openalex.org/S2764455111 |
| locations[3].source.issn | |
| locations[3].source.type | repository |
| locations[3].source.is_oa | False |
| locations[3].source.issn_l | |
| locations[3].source.is_core | False |
| locations[3].source.is_in_doaj | False |
| locations[3].source.display_name | PubMed Central |
| locations[3].source.host_organization | https://openalex.org/I1299303238 |
| locations[3].source.host_organization_name | National Institutes of Health |
| locations[3].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[3].license | other-oa |
| locations[3].pdf_url | |
| locations[3].version | submittedVersion |
| locations[3].raw_type | Text |
| locations[3].license_id | https://openalex.org/licenses/other-oa |
| locations[3].is_accepted | False |
| locations[3].is_published | False |
| locations[3].raw_source_name | Sci Rep |
| locations[3].landing_page_url | https://www.ncbi.nlm.nih.gov/pmc/articles/12217157 |
| indexed_in | crossref, doaj, pubmed |
| authorships[0].author.id | https://openalex.org/A5006804085 |
| authorships[0].author.orcid | |
| authorships[0].author.display_name | Sanaz Borji |
| authorships[0].countries | IR |
| authorships[0].affiliations[0].institution_ids | https://openalex.org/I4210098966 |
| authorships[0].affiliations[0].raw_affiliation_string | Department of Biology, Ra.C., Islamic Azad University, Rasht, P.O. Box: 3516-41335, Iran. |
| authorships[0].institutions[0].id | https://openalex.org/I4210098966 |
| authorships[0].institutions[0].ror | https://ror.org/0151gh112 |
| authorships[0].institutions[0].type | education |
| authorships[0].institutions[0].lineage | https://openalex.org/I110525433, https://openalex.org/I4210098966 |
| authorships[0].institutions[0].country_code | IR |
| authorships[0].institutions[0].display_name | Islamic Azad University Rasht Branch |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | Sanaz Borji |
| authorships[0].is_corresponding | False |
| authorships[0].raw_affiliation_strings | Department of Biology, Ra.C., Islamic Azad University, Rasht, P.O. Box: 3516-41335, Iran. |
| authorships[1].author.id | https://openalex.org/A5058351491 |
| authorships[1].author.orcid | https://orcid.org/0000-0002-4596-591X |
| authorships[1].author.display_name | Mahdi Shahriarinour |
| authorships[1].countries | IR |
| authorships[1].affiliations[0].institution_ids | https://openalex.org/I4210098966 |
| authorships[1].affiliations[0].raw_affiliation_string | Department of Biology, Ra.C., Islamic Azad University, Rasht, P.O. Box: 3516-41335, Iran. [email protected]. |
| authorships[1].institutions[0].id | https://openalex.org/I4210098966 |
| authorships[1].institutions[0].ror | https://ror.org/0151gh112 |
| authorships[1].institutions[0].type | education |
| authorships[1].institutions[0].lineage | https://openalex.org/I110525433, https://openalex.org/I4210098966 |
| authorships[1].institutions[0].country_code | IR |
| authorships[1].institutions[0].display_name | Islamic Azad University Rasht Branch |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | Mahdi Shahriarinour |
| authorships[1].is_corresponding | False |
| authorships[1].raw_affiliation_strings | Department of Biology, Ra.C., Islamic Azad University, Rasht, P.O. Box: 3516-41335, Iran. [email protected]. |
| authorships[2].author.id | https://openalex.org/A5018031129 |
| authorships[2].author.orcid | https://orcid.org/0000-0001-7647-0285 |
| authorships[2].author.display_name | Shahab Shariati |
| authorships[2].countries | IR |
| authorships[2].affiliations[0].institution_ids | https://openalex.org/I4210098966 |
| authorships[2].affiliations[0].raw_affiliation_string | Department of Chemistry, Ra.C., Islamic Azad University, Rasht, Iran. |
| authorships[2].institutions[0].id | https://openalex.org/I4210098966 |
| authorships[2].institutions[0].ror | https://ror.org/0151gh112 |
| authorships[2].institutions[0].type | education |
| authorships[2].institutions[0].lineage | https://openalex.org/I110525433, https://openalex.org/I4210098966 |
| authorships[2].institutions[0].country_code | IR |
| authorships[2].institutions[0].display_name | Islamic Azad University Rasht Branch |
| authorships[2].author_position | middle |
| authorships[2].raw_author_name | Shahab Shariati |
| authorships[2].is_corresponding | False |
| authorships[2].raw_affiliation_strings | Department of Chemistry, Ra.C., Islamic Azad University, Rasht, Iran. |
| authorships[3].author.id | https://openalex.org/A5049549726 |
| authorships[3].author.orcid | |
| authorships[3].author.display_name | Najmeh Ranji |
| authorships[3].countries | IR |
| authorships[3].affiliations[0].institution_ids | https://openalex.org/I4210098966 |
| authorships[3].affiliations[0].raw_affiliation_string | Department of Biology, Ra.C., Islamic Azad University, Rasht, P.O. Box: 3516-41335, Iran. |
| authorships[3].institutions[0].id | https://openalex.org/I4210098966 |
| authorships[3].institutions[0].ror | https://ror.org/0151gh112 |
| authorships[3].institutions[0].type | education |
| authorships[3].institutions[0].lineage | https://openalex.org/I110525433, https://openalex.org/I4210098966 |
| authorships[3].institutions[0].country_code | IR |
| authorships[3].institutions[0].display_name | Islamic Azad University Rasht Branch |
| authorships[3].author_position | middle |
| authorships[3].raw_author_name | Najmeh Ranji |
| authorships[3].is_corresponding | False |
| authorships[3].raw_affiliation_strings | Department of Biology, Ra.C., Islamic Azad University, Rasht, P.O. Box: 3516-41335, Iran. |
| authorships[4].author.id | https://openalex.org/A5051346789 |
| authorships[4].author.orcid | https://orcid.org/0000-0002-9692-6849 |
| authorships[4].author.display_name | Mohammad Nikpassand |
| authorships[4].countries | IR |
| authorships[4].affiliations[0].institution_ids | https://openalex.org/I4210098966 |
| authorships[4].affiliations[0].raw_affiliation_string | Department of Chemistry, Ra.C., Islamic Azad University, Rasht, Iran. |
| authorships[4].institutions[0].id | https://openalex.org/I4210098966 |
| authorships[4].institutions[0].ror | https://ror.org/0151gh112 |
| authorships[4].institutions[0].type | education |
| authorships[4].institutions[0].lineage | https://openalex.org/I110525433, https://openalex.org/I4210098966 |
| authorships[4].institutions[0].country_code | IR |
| authorships[4].institutions[0].display_name | Islamic Azad University Rasht Branch |
| authorships[4].author_position | last |
| authorships[4].raw_author_name | Mohammad Nikpassand |
| authorships[4].is_corresponding | False |
| authorships[4].raw_affiliation_strings | Department of Chemistry, Ra.C., Islamic Azad University, Rasht, Iran. |
| has_content.pdf | False |
| has_content.grobid_xml | False |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | https://doi.org/10.1038/s41598-025-07529-x |
| open_access.oa_status | gold |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-10-10T00:00:00 |
| display_name | Enhanced therapeutic efficacy of silibinin loaded silica coated magnetic nanocomposites against Pseudomonas aeruginosa in Combination with Ciprofloxacin and HepG2 cancer cells |
| has_fulltext | False |
| is_retracted | False |
| updated_date | 2025-11-06T03:46:38.306776 |
| primary_topic.id | https://openalex.org/T10063 |
| primary_topic.field.id | https://openalex.org/fields/25 |
| primary_topic.field.display_name | Materials Science |
| primary_topic.score | 0.9979000091552734 |
| primary_topic.domain.id | https://openalex.org/domains/3 |
| primary_topic.domain.display_name | Physical Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/2502 |
| primary_topic.subfield.display_name | Biomaterials |
| primary_topic.display_name | Nanoparticle-Based Drug Delivery |
| related_works | https://openalex.org/W2356020233, https://openalex.org/W2389192791, https://openalex.org/W4225388254, https://openalex.org/W4400682660, https://openalex.org/W2122116421, https://openalex.org/W4401021064, https://openalex.org/W3024947463, https://openalex.org/W4407060210, https://openalex.org/W2171660964, https://openalex.org/W2764329203 |
| cited_by_count | 1 |
| counts_by_year[0].year | 2025 |
| counts_by_year[0].cited_by_count | 1 |
| locations_count | 4 |
| best_oa_location.id | doi:10.1038/s41598-025-07529-x |
| best_oa_location.is_oa | True |
| best_oa_location.source.id | https://openalex.org/S196734849 |
| best_oa_location.source.issn | 2045-2322 |
| best_oa_location.source.type | journal |
| best_oa_location.source.is_oa | True |
| best_oa_location.source.issn_l | 2045-2322 |
| best_oa_location.source.is_core | True |
| best_oa_location.source.is_in_doaj | True |
| best_oa_location.source.display_name | Scientific Reports |
| best_oa_location.source.host_organization | https://openalex.org/P4310319908 |
| best_oa_location.source.host_organization_name | Nature Portfolio |
| best_oa_location.source.host_organization_lineage | https://openalex.org/P4310319908 |
| best_oa_location.license | |
| best_oa_location.pdf_url | |
| best_oa_location.version | publishedVersion |
| best_oa_location.raw_type | journal-article |
| best_oa_location.license_id | |
| best_oa_location.is_accepted | True |
| best_oa_location.is_published | True |
| best_oa_location.raw_source_name | Scientific Reports |
| best_oa_location.landing_page_url | https://doi.org/10.1038/s41598-025-07529-x |
| primary_location.id | doi:10.1038/s41598-025-07529-x |
| primary_location.is_oa | True |
| primary_location.source.id | https://openalex.org/S196734849 |
| primary_location.source.issn | 2045-2322 |
| primary_location.source.type | journal |
| primary_location.source.is_oa | True |
| primary_location.source.issn_l | 2045-2322 |
| primary_location.source.is_core | True |
| primary_location.source.is_in_doaj | True |
| primary_location.source.display_name | Scientific Reports |
| primary_location.source.host_organization | https://openalex.org/P4310319908 |
| primary_location.source.host_organization_name | Nature Portfolio |
| primary_location.source.host_organization_lineage | https://openalex.org/P4310319908 |
| primary_location.license | |
| primary_location.pdf_url | |
| primary_location.version | publishedVersion |
| primary_location.raw_type | journal-article |
| primary_location.license_id | |
| primary_location.is_accepted | True |
| primary_location.is_published | True |
| primary_location.raw_source_name | Scientific Reports |
| primary_location.landing_page_url | https://doi.org/10.1038/s41598-025-07529-x |
| publication_date | 2025-07-01 |
| publication_year | 2025 |
| referenced_works | https://openalex.org/W3136115842, https://openalex.org/W4392291911, https://openalex.org/W4402749776, https://openalex.org/W4224996603, https://openalex.org/W4281710050, https://openalex.org/W4376132005, https://openalex.org/W4225133146, https://openalex.org/W4404597853, https://openalex.org/W4383907637, https://openalex.org/W3072290310, https://openalex.org/W4309737291, https://openalex.org/W4225983641, https://openalex.org/W2945049818, https://openalex.org/W2979558755, https://openalex.org/W2916907885, https://openalex.org/W4313544471, https://openalex.org/W3016029850, https://openalex.org/W1809721560, https://openalex.org/W4321235262, https://openalex.org/W4390471455, https://openalex.org/W4376614822, https://openalex.org/W4226161340, https://openalex.org/W4281679483, https://openalex.org/W3133390118, https://openalex.org/W4394767718, https://openalex.org/W4375956061, https://openalex.org/W3217358971, https://openalex.org/W4387964910, https://openalex.org/W4281788071, https://openalex.org/W4308365352, https://openalex.org/W4407203875, https://openalex.org/W4408155573, https://openalex.org/W4399572972, https://openalex.org/W4391927412, https://openalex.org/W4292393391, https://openalex.org/W4403636529, https://openalex.org/W4321334381, https://openalex.org/W4403626271, https://openalex.org/W3217184868, https://openalex.org/W2328252312, https://openalex.org/W2609278286, https://openalex.org/W4407142491, https://openalex.org/W2890427706, https://openalex.org/W4205497092, https://openalex.org/W4400320682, https://openalex.org/W4396762072, https://openalex.org/W3166477023, https://openalex.org/W4403853541, https://openalex.org/W3193743580, https://openalex.org/W4409375848, https://openalex.org/W4408378340, https://openalex.org/W4391885020, https://openalex.org/W4403380622, https://openalex.org/W4296356674, https://openalex.org/W4394893483, https://openalex.org/W4407546403, https://openalex.org/W4382936537, https://openalex.org/W3014336421, https://openalex.org/W2970111204, https://openalex.org/W2763925781, https://openalex.org/W2340662778, https://openalex.org/W2095203833, https://openalex.org/W2138142499, https://openalex.org/W2766720790, https://openalex.org/W2073350510, https://openalex.org/W4292444287, https://openalex.org/W4381430247, https://openalex.org/W4406305050, https://openalex.org/W4386194161, https://openalex.org/W2946151277, https://openalex.org/W4307134790, https://openalex.org/W3127845922, https://openalex.org/W4293195211, https://openalex.org/W4366216801, https://openalex.org/W2948713507, https://openalex.org/W2131985267, https://openalex.org/W1800870937, https://openalex.org/W3164545139, https://openalex.org/W3006240142, https://openalex.org/W4214726605, https://openalex.org/W2070262613, https://openalex.org/W4402921760, https://openalex.org/W2944421454, https://openalex.org/W2099215442, https://openalex.org/W3160850696, https://openalex.org/W3165718866 |
| referenced_works_count | 86 |
| abstract_inverted_index.a | 1, 74, 142, 231 |
| abstract_inverted_index.40 | 120 |
| abstract_inverted_index.80 | 122 |
| abstract_inverted_index.In | 171 |
| abstract_inverted_index.P. | 78, 214 |
| abstract_inverted_index.an | 165 |
| abstract_inverted_index.by | 34, 62 |
| abstract_inverted_index.in | 87, 110, 133 |
| abstract_inverted_index.of | 32, 46, 56, 77, 106, 129, 144, 168, 176, 182, 225 |
| abstract_inverted_index.to | 28, 97, 121, 141, 152 |
| abstract_inverted_index.(at | 84 |
| abstract_inverted_index.Our | 188 |
| abstract_inverted_index.P53 | 178 |
| abstract_inverted_index.The | 53, 113 |
| abstract_inverted_index.VSM | 69 |
| abstract_inverted_index.and | 14, 39, 49, 68, 73, 92, 146, 180, 196, 205, 216, 222 |
| abstract_inverted_index.can | 199 |
| abstract_inverted_index.for | 234 |
| abstract_inverted_index.its | 18, 22, 210, 235 |
| abstract_inverted_index.led | 140 |
| abstract_inverted_index.nm, | 123 |
| abstract_inverted_index.the | 30, 57, 93, 103, 126, 177, 183, 220 |
| abstract_inverted_index.Bcl2 | 184 |
| abstract_inverted_index.TEM, | 65 |
| abstract_inverted_index.This | 25 |
| abstract_inverted_index.XRD, | 67 |
| abstract_inverted_index.from | 6, 119 |
| abstract_inverted_index.gene | 149, 179, 185 |
| abstract_inverted_index.high | 194 |
| abstract_inverted_index.into | 203 |
| abstract_inverted_index.plus | 138 |
| abstract_inverted_index.poor | 19 |
| abstract_inverted_index.that | 190 |
| abstract_inverted_index.used | 132 |
| abstract_inverted_index.were | 60, 80, 95, 108, 186 |
| abstract_inverted_index.when | 131 |
| abstract_inverted_index.with | 82, 89, 99, 115, 136, 164, 193 |
| abstract_inverted_index.35.79 | 169 |
| abstract_inverted_index.Given | 219 |
| abstract_inverted_index.HepG2 | 50, 111, 162, 173, 217 |
| abstract_inverted_index.MNCs, | 192 |
| abstract_inverted_index.aimed | 27 |
| abstract_inverted_index.major | 2 |
| abstract_inverted_index.sizes | 117 |
| abstract_inverted_index.study | 26 |
| abstract_inverted_index.their | 41 |
| abstract_inverted_index.these | 227 |
| abstract_inverted_index.value | 167 |
| abstract_inverted_index.water | 197 |
| abstract_inverted_index.(MNCs) | 38 |
| abstract_inverted_index.FT-IR, | 63 |
| abstract_inverted_index.alone. | 101, 155 |
| abstract_inverted_index.cancer | 51 |
| abstract_inverted_index.cells, | 163, 174, 207 |
| abstract_inverted_index.cells. | 52, 112, 218 |
| abstract_inverted_index.efflux | 147 |
| abstract_inverted_index.level) | 86 |
| abstract_inverted_index.limits | 21 |
| abstract_inverted_index.strain | 76 |
| abstract_inverted_index.µg/mL | 170 |
| abstract_inverted_index.FE-SEM, | 66 |
| abstract_inverted_index.Silybum | 7 |
| abstract_inverted_index.against | 43, 161, 213 |
| abstract_inverted_index.biofilm | 145 |
| abstract_inverted_index.deliver | 201 |
| abstract_inverted_index.effects | 105, 212 |
| abstract_inverted_index.enhance | 29 |
| abstract_inverted_index.notable | 10 |
| abstract_inverted_index.ranging | 118 |
| abstract_inverted_index.results | 94 |
| abstract_inverted_index.sub-MIC | 85 |
| abstract_inverted_index.thereby | 208 |
| abstract_inverted_index.treated | 81 |
| abstract_inverted_index.Clinical | 71 |
| abstract_inverted_index.However, | 17 |
| abstract_inverted_index.IC₅₀ | 166 |
| abstract_inverted_index.TGA-DTG, | 64 |
| abstract_inverted_index.activity | 128, 160 |
| abstract_inverted_index.clinical | 23, 44 |
| abstract_inverted_index.compared | 96, 151 |
| abstract_inverted_index.compound | 4 |
| abstract_inverted_index.delivery | 31 |
| abstract_inverted_index.efficacy | 42 |
| abstract_inverted_index.enhanced | 125 |
| abstract_inverted_index.isolates | 45, 72 |
| abstract_inverted_index.magnetic | 36, 228 |
| abstract_inverted_index.particle | 116 |
| abstract_inverted_index.standard | 75 |
| abstract_inverted_index.strategy | 233 |
| abstract_inverted_index.targeted | 236 |
| abstract_inverted_index.Treatment | 135 |
| abstract_inverted_index.analysis. | 70 |
| abstract_inverted_index.antitumor | 223 |
| abstract_inverted_index.bioactive | 3 |
| abstract_inverted_index.delivery. | 237 |
| abstract_inverted_index.enhancing | 209 |
| abstract_inverted_index.evaluated | 109 |
| abstract_inverted_index.exhibited | 158 |
| abstract_inverted_index.extracted | 5 |
| abstract_inverted_index.marianum, | 8 |
| abstract_inverted_index.observed. | 187 |
| abstract_inverted_index.possesses | 9 |
| abstract_inverted_index.promising | 232 |
| abstract_inverted_index.represent | 230 |
| abstract_inverted_index.silibinin | 33, 202 |
| abstract_inverted_index.stability | 195 |
| abstract_inverted_index.treatment | 98, 154 |
| abstract_inverted_index.(sub-MIC), | 91 |
| abstract_inverted_index.Silibinin, | 0 |
| abstract_inverted_index.aeruginosa | 48, 79, 215 |
| abstract_inverted_index.anticancer | 104 |
| abstract_inverted_index.antitumor, | 12 |
| abstract_inverted_index.evaluating | 40 |
| abstract_inverted_index.expression | 150 |
| abstract_inverted_index.pathogenic | 204 |
| abstract_inverted_index.properties | 55, 224 |
| abstract_inverted_index.silibinin, | 226 |
| abstract_inverted_index.solubility | 20 |
| abstract_inverted_index.solublity, | 198 |
| abstract_inverted_index.Pseudomonas | 47 |
| abstract_inverted_index.activities. | 16 |
| abstract_inverted_index.anti-cancer | 159 |
| abstract_inverted_index.combination | 88 |
| abstract_inverted_index.efficiently | 200 |
| abstract_inverted_index.therapeutic | 211 |
| abstract_inverted_index.tumorigenic | 206 |
| abstract_inverted_index.Furthermore, | 156 |
| abstract_inverted_index.antioxidant, | 11 |
| abstract_inverted_index.combination. | 134 |
| abstract_inverted_index.nanocarriers | 229 |
| abstract_inverted_index.pump-related | 148 |
| abstract_inverted_index.synthesizing | 35 |
| abstract_inverted_index.upregulation | 175 |
| abstract_inverted_index.Additionally, | 102 |
| abstract_inverted_index.antibacterial | 15 |
| abstract_inverted_index.antimicrobial | 127, 221 |
| abstract_inverted_index.applications. | 24 |
| abstract_inverted_index.characterized | 61 |
| abstract_inverted_index.ciprofloxacin | 90, 100, 130, 139, 153 |
| abstract_inverted_index.significantly | 124 |
| abstract_inverted_index.downregulation | 143, 181 |
| abstract_inverted_index.nanocomposites | 37, 59 |
| abstract_inverted_index.findingssuggest | 189 |
| abstract_inverted_index.nanocomposites, | 114 |
| abstract_inverted_index.physicochemical | 54 |
| abstract_inverted_index.Silibinin-treated | 172 |
| abstract_inverted_index.hepatoprotective, | 13 |
| abstract_inverted_index.Fe<sub>3</sub>O<sub>4</sub>@SiPr@Silibinin | 58, 83, 107, 137, 157, 191 |
| cited_by_percentile_year.max | 95 |
| cited_by_percentile_year.min | 91 |
| countries_distinct_count | 1 |
| institutions_distinct_count | 5 |
| citation_normalized_percentile.value | 0.76997812 |
| citation_normalized_percentile.is_in_top_1_percent | False |
| citation_normalized_percentile.is_in_top_10_percent | False |